Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Frederic Colombel

Showing results (211-220 of 462) with videos related to

Pageof 47
Sort By:
The American Journal of Gastroenterology|November 6, 2020
Data Visualization in the Era of COVID-19: An Interactive Map of the SECURE-IBD RegistryJoseph W Windsor, Fox E Underwood, Erica Brenner, et al.
Gut|August 23, 2024
Emerging role of environmental pollutants in inflammatory bowel disease risk, outcomes and underlying mechanismsMaria Manuela Estevinho, Vishal Midya, Shirley Cohen-Mekelburg, et al.
The American Journal of Gastroenterology|July 18, 2023
P037 Effect of Ozanimod Treatment and Discontinuation on Absolute Lymphocyte Count in Moderate-to-Severe Ulcerative Colitis: Results from a Phase 3 TrialJean-Frederic Colombel, Geert D'Haens, Peter Irving, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 17, 2013
Treat to target: a proposed new paradigm for the management of Crohn's diseaseGuillaume Bouguen, Barrett G Levesque, Brian G Feagan, et al.
Scientific Reports|July 13, 2016
Polymorphisms in the Mannose-Binding Lectin Gene are Associated with Defective Mannose-Binding Lectin Functional Activity in Crohn's Disease PatientsLaura Choteau, Francis Vasseur, Frederic Lepretre, et al.
Contemporary Clinical Trials|November 19, 2025
Combination Therapy of Resilience Intervention with Biologics in Crohn's Disease (CATHARSIS): Study protocol for a randomized controlled trialLaurie Keefer, Ryan Ungaro, Ayanna Lewis, et al.
Gut|March 26, 2021
Predicting endoscopic remission in Crohn's disease by the modified multiplier SES-CD (MM-SES-CD)Neeraj Narula, Emily C L Wong, Jean-Frederic Colombel, et al.
Inflammatory Bowel Diseases|May 7, 2025
Understanding Pouch-Related Fistulae: Don't Lose Track of TimeSergio Bronze, Serre-Yu Wong, Haley Waite, et al.
Scientific Reports|January 3, 2024
Cytokine signature in convalescent SARS-CoV-2 patients with inflammatory bowel disease receiving vedolizumabSimone Dallari, Vicky Martinez Pazos, Juan Munoz Eusse, et al.
Journal of Crohn'S & Colitis|October 19, 2021
Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn's DiseaseNeeraj Narula, Emily C L Wong, Jean-Frederic Colombel, et al.
Pageof 47

Showing results (211-220 of 462) with videos related to

Sort By:
Pageof 47
The American Journal of Gastroenterology|November 6, 2020
Data Visualization in the Era of COVID-19: An Interactive Map of the SECURE-IBD RegistryJoseph W Windsor, Fox E Underwood, Erica Brenner, et al.
Gut|August 23, 2024
Emerging role of environmental pollutants in inflammatory bowel disease risk, outcomes and underlying mechanismsMaria Manuela Estevinho, Vishal Midya, Shirley Cohen-Mekelburg, et al.
The American Journal of Gastroenterology|July 18, 2023
P037 Effect of Ozanimod Treatment and Discontinuation on Absolute Lymphocyte Count in Moderate-to-Severe Ulcerative Colitis: Results from a Phase 3 TrialJean-Frederic Colombel, Geert D'Haens, Peter Irving, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 17, 2013
Treat to target: a proposed new paradigm for the management of Crohn's diseaseGuillaume Bouguen, Barrett G Levesque, Brian G Feagan, et al.
Scientific Reports|July 13, 2016
Polymorphisms in the Mannose-Binding Lectin Gene are Associated with Defective Mannose-Binding Lectin Functional Activity in Crohn's Disease PatientsLaura Choteau, Francis Vasseur, Frederic Lepretre, et al.
Contemporary Clinical Trials|November 19, 2025
Combination Therapy of Resilience Intervention with Biologics in Crohn's Disease (CATHARSIS): Study protocol for a randomized controlled trialLaurie Keefer, Ryan Ungaro, Ayanna Lewis, et al.
Gut|March 26, 2021
Predicting endoscopic remission in Crohn's disease by the modified multiplier SES-CD (MM-SES-CD)Neeraj Narula, Emily C L Wong, Jean-Frederic Colombel, et al.
Inflammatory Bowel Diseases|May 7, 2025
Understanding Pouch-Related Fistulae: Don't Lose Track of TimeSergio Bronze, Serre-Yu Wong, Haley Waite, et al.
Scientific Reports|January 3, 2024
Cytokine signature in convalescent SARS-CoV-2 patients with inflammatory bowel disease receiving vedolizumabSimone Dallari, Vicky Martinez Pazos, Juan Munoz Eusse, et al.
Journal of Crohn'S & Colitis|October 19, 2021
Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn's DiseaseNeeraj Narula, Emily C L Wong, Jean-Frederic Colombel, et al.
Pageof 47